Download PDF
Hamostaseologie 1983; 03(04): 140-148
DOI: 10.1055/s-0038-1656630
Originalarbeiten
Schattauer GmbH

Therapeutische Möglichkeiten zur Normalisierung der Glukosehomöostase bei Diabetikern

W. Waldhäusl
1   Aus der Abteilung für Klinische Endokrinologie und Diabetes mellitus, 1. Medizinische Universitätsklinik (Vorstand: Prof. Dr. Dr. h. c. E. Deutsch), Wien
› Author Affiliations
Further Information

Publication History

Publication Date:
22 June 2018 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Das Ziel einer sachgerechten Diabetestherapie ist stets die weitgehende Anpassung der Stoffwechselsituation des Diabetikers an normale metabolische Verhältnisse. Die Motivation für die dafür unbedingt nötige Mitarbeit des Patienten ist die begründete Hoffnung, daß auf diese Weise die Entstehung des diabetischen Spätsyndroms verzögert oder sogar verhindert werden kann. Für das Erreichen dieses Zieles ist jedoch ein beträchtliches Verständnis des betroffenen Patienten für seine Erkrankung und deren Behandlung erforderlich. Das bedeutet im Fall des nicht insulinabhängigen Diabetikers vor allem ein Bewußtmachen der Zusammenhänge zwischen der Hyperglykämie einerseits und dem Körpergewicht, der Kalorienzufuhr und einer allfälligen Medikation mit oralen Antidiabetika andererseits. Diese Forderung gilt in noch viel höherem Maße für insulinabhängige Diabetiker, die für eine sinnvolle Mitarbeit ein ausreichendes praktizierbares Wissen über das akute Zusammenspiel von Insulin, Nahrungszufuhr und körperlicher Tätigkeit erwerben müssen. Die wichtigste, vom Arzt für das Erreichen einer langfristig erfolgreichen Stoffwechselkontrolle insulinabhängiger Diabetiker zu erbringende Leistung ist eine stets motivierende Hinwendung zum Patienten, die oft mehr Mitarbeit und Selbstkontrolle erreicht als ein übertriebener pädagogischer Drill.

 

  • LITERATUR

  • 1 Minkowski O. Untersuchungen über den Diabetes mellitus nach Exstirpation des Pankreas. Arch. Exp. Path. Pharmakol 1883; 31: 85-189.
    PubMedSearch in Google Scholar
  • 2 Himsworth H. The syndrome of diabetes mellitus and its causes. Lancet 1949; I: 465-472.
    PubMedSearch in Google Scholar
  • 3 Nerup J, Platz P, Andersen O. O, Christy M, Egeberg J, Lyngsoe J, Poulsen J. E, Ryder L. P, Thomsen M, Svejgaard A. HLA, autoimmunity and insulin dependent diabetes mellitus. In Creutzfeldt W, Köbberling J. The Genetics of Diabetes Mellitus Springer; Berlin – Heidelberg -New York: 1976
    Search in Google Scholar
  • 4 Craighead J. E. The role of viruses in the pathogenesis of pancreatic disease and diabetes mellitus. Progr. Med. Virol 1975; 19: 161-214.
    PubMedSearch in Google Scholar
  • 5 Karam J. H, Lewitt P. A, Young C. W, Nowlain R. E, Frankel B. J, Fujiya J, Freedman Z. R, Grodsky G. M. Insulinogenic diabetes after rodenticide (Vacor) ingestion: a unique model of acquired diabetes in man. Diabetes 1980; 29: 971-978.
    CrossrefPubMedSearch in Google Scholar
  • 6 Czech M. P. Cellular basis of insulin insen-sitivity in large rat adipocytes. J. Clin. Invest 1976; 55: 1523-1532.
    PubMedSearch in Google Scholar
  • 7 Olefsky J. M, Reaven G. M. Insulin binding in diabetes: relationship with plasma insulin levels and insulin sensitivity. Diabetes 1977; 26: 680-688.
    CrossrefPubMedSearch in Google Scholar
  • 8 Waldhäusl W, Kleinberger G. Die Therapie des ketoazidotischen und hyperosmolalen Coma diabeticum. Pharmakotherapie 1980; 3: 129-138.
    PubMedSearch in Google Scholar
  • 9 McMillan D. E, Utterback N. G, La Puma J. Reduced erythrocyte deformability in diabetes. Diabetes 1978; 27: 895-901.
    CrossrefPubMedSearch in Google Scholar
  • 10 Juhan I, Vague P, Buonocore M, Moulin J. P, Calas M. F, Vialettes B, Verdot J. J. Effects of insulin on erythrocyte deformability in diabetes – relationship between erythrocyte deformability and platelet aggregation. Scand. J. Clin. Lab. Invest 1981; 41: 159-164.
    PubMedSearch in Google Scholar
  • 11 McMillan D. E. Insulin, diabetes, and the cell membrane: An hypothesis. Diabetologia 1983; 24: 308-310.
    PubMedSearch in Google Scholar
  • 12 Drouin P, Rousselle D, Stoltz J. F, Guimont C, Gaillard S, Vernhes G, De-bry G. Study of blood viscosity and erythrocyte parameters in diabetic patients using an artificial pancreas. Scand. J. Clin. Lab. Invest 1981; 41 Suppl (Suppl. 156) 165-169.
    CrossrefPubMedSearch in Google Scholar
  • 13 Dintenfass L. Haemorheology of diabetes mellitus. Adv. Microcirc 1979; 8: 14-36.
    PubMedSearch in Google Scholar
  • 14 Ødegaard A. E, Skalhegg B. A, Hellem A. J. Increased activity of »anti-Wille-brand-factor« in diabetic plasma. Thrombos. Diathes. haemorrh 1964; 21: 27-37.
    PubMedSearch in Google Scholar
  • 15 Heath H, Bridgen W. D, Canever J. V, Pollock J, Hunter P. R, Kelsey J. Platelet adhesiveness and aggregation in relation to diabetic retinopathy. Diabetologia 1971; 7: 308-315.
    CrossrefPubMedSearch in Google Scholar
  • 16 Gensini G. F, Abbate R, Favilla S, Neri Serneri G. G. Changes of platelet function and blood clotting in diabetes mellitus. Thromb. Haemostas 1979; 42: 983-993.
    PubMedSearch in Google Scholar
  • 17 Rasch R. Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment: Glomerular basement membrane thickness. Diabetologia 1979; 16: 319-324.
    CrossrefPubMedSearch in Google Scholar
  • 18 Cahill G. F, Etzwiller D. D, Freinkel N. “Control” and diabetes. N. Engl. J. Med 1976; 294: 1004
    CrossrefPubMedSearch in Google Scholar
  • 19 Opie E. L. Disease of pancreas. J. B. LippincottM; Philadelphia: 1910
    Search in Google Scholar
  • 20 Gepts W, Le Compte P. M. The pancreatic islets in diabetes. Am. J. Med 1981; 70: 105-115.
    CrossrefPubMedSearch in Google Scholar
  • 21 Botazzo G. F, Florin-Christensen A, Doniach D. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974; II: 1279-1283.
    PubMedSearch in Google Scholar
  • 22 Gorsuch A. N, Spencer K. M, Lister J, McNally J. M, Dean B. M, Botazzo G. F, Cudworth A. G. Evidence for a long prediabetic period in type I (insulin dependent) diabetes mellitus. Lancet 1981; II: 1363-1365.
    PubMedSearch in Google Scholar
  • 23 Banting F. G, Best C. H, Campbell W. R, Fletcher A. A. Pancreatic extract in the treatment of diabetes mellitus. Can. Med. Ass. J 1922; 12: 141-146.
    PubMedSearch in Google Scholar
  • 24 Freinkel N. Pregnant thoughts about metabolic control and diabetes. N. Engl. J. Med 1981; 304: 1357-1359.
    CrossrefPubMedSearch in Google Scholar
  • 25 Miller W. L, Baxter J. D. Recombinant DNA. A new source of insulin. Diabetologia 1980; 18: 431-435.
    PubMedSearch in Google Scholar
  • 26 Worth R. P. D. Home, Johnston D. G, Anderson J, Ashworth L, Burrin J. M, Appleton D, Binder C, Alberti K. G. M. M. Intensive alteration improves glycaemic control in insulin-dependent diabetes without further advantages from home blood glucose monitoring. Results of a controlled trial. Brit. Med. J 1982; 285: 1233-1240.
    PubMedSearch in Google Scholar
  • 27 Bernstein R. K. Diabetes. The Glucograf Method for Normalizing Blood Sugar. Crown Publishers; New York: 1981
    Search in Google Scholar
  • 28 Waldhäusl W, Bratusch-Marrain P. R, Vierhapper H, Nowotny P. Insulin pharmacokinetics following continuous infusion and bolus injection of regular porcine and human insulin in healthy man. Metabolism 1983; 32: 478-486.
    CrossrefPubMedSearch in Google Scholar
  • 29 Waldhäusl W, Bratusch-Marrain P, Francesconi M, Nowotny P, Kiss A. Insulin production rate in normal man as an estimate for calibration of continuous intravenous insulin infusion in insulin dependent diabetics. Diabetes Care 1982; 5: 18-24.
    CrossrefPubMedSearch in Google Scholar
  • 30 Zinman B, Murray F. T, Vranic M, Albisser A. M, Leibel B. S, Mc Clean P. A, Marliss E. B. Glucoregulation during moderate exercise in insulin treated diabetics. J. Clin. Endocrinol. Metab 1977; 45: 641-652.
    CrossrefPubMedSearch in Google Scholar
  • 31 Bratusch-Marrain P, Waldhäusl W, Grubeck-Loebenstein B, Korn A, Vierhapper H, Nowotny P. The role of “diabetogenic” hormones on carbohydrate and lipid metabolism following oral glucose loading in insulin dependent diabetics: Effects of acute hormone administration. Diabetologia 1981; 21: 387-393.
    PubMedSearch in Google Scholar
  • 32 Waldhäusl W, Kastner G, Komjati M, Bratusch-Marrain P. Studies on biological actions of biosynthetic human insulin in vitro and in diabetic man. Diabetes Care 1981; 4: 205-208.
    CrossrefPubMedSearch in Google Scholar
  • 33 Waldhäusl W. Insulinbindende Antikörper und Insulinresistenz. Klin. Wschr 1973; 85: 833-836.
    PubMedSearch in Google Scholar
  • 34 Waldhäusl W. Treatment of diabetes mellitus: Pathophysiological aspects and state of the art. In Waldhäusl W. (Ed.) Diabetes 1979. International Congress Series 1980; 500: 10-22. Excerpta Medica. Amsterdam
    PubMedSearch in Google Scholar
  • 35 Albisser A. M, Leibel B. S, Ewart T. G, Davidovac Z, Botz C. K, Zingg W. An artificial endocrine pancreas. Diabetes 1974; 23: 388-396.
    PubMedSearch in Google Scholar
  • 36 Pfeiffer E. F, Thum Ch, Clemens A. H. Die künstliche Beta-Zelle. Naturwissenschaften 1974; 61: 455
    PubMedSearch in Google Scholar
  • 37 Hepp K. D, Renner R, Funcke H. J. v, Mehnert H, Haerten R, Kresse H. Intravenous insulin therapy under conditions imitating physiological profiles. Diabetologia 1975; 11: 349
    PubMedSearch in Google Scholar
  • 38 Pickup J. C, White M. C, Keen H, Kohner E. M, Parsons J. A, Alberti K. G. M. M. Long term continuous subcutaneous insulin infusion in diabetics at home. Lancet 1979; II: 870-873.
    PubMedSearch in Google Scholar
  • 39 Schade D, Eaton R. P, Spencer W. J, Edwards W. S, Doberneck R. Implantation of a remotely controlled insulin pump in diabetic man. Diabetes 1981; 30 Suppl (Suppl. 01) 15 A
    PubMedSearch in Google Scholar
  • 40 Buchwald H, Varco R. L, Rupp W. M, Goldenberg F. J, Barbosa J, Rohde T. D, Schwartz R. A, Ruble T. G, Blackshear P. J. Treatment of a type II diabetic by a totally implantable insulin infusion device. Lancet I 1981; 1233-1234.
    PubMedSearch in Google Scholar
  • 41 Waldhäusl W, Freyler H, Bratusch-Marrain P, Vierhapper H, Bruneder H. Kontinuierliche subkutane Insulininfusion (CSII) : Langzeitbehandlung einer unselek-tierten Gruppe insulinabhängiger Diabetiker. Dtsch. med. Wschr 1983; 108: 570-577.
    Thieme ConnectPubMedSearch in Google Scholar
  • 42 Lauritzen T, Frost-Larson K, Larsen H. W, Deckert T. the Steno Study Group: Effect of 1 year of near normal blood glucose levels on retinopathy in insulin dependent diabetics. Lancet I 1983; 200-204.
    PubMedSearch in Google Scholar
  • 43 Zimmet P. Type 2 (non-insulin-dependent) Diabetes. An epidemiological overview. Diabetologia 1982; 22: 399-411.
    CrossrefPubMedSearch in Google Scholar
  • 44 Harris M. The prevalence of diagnosed diabetes., undiagnosed diabetes, and impaired glucose tolerance in the United States. In Melish J. S, Hanna J. Babas. (Eds.) Genetic Environmental Interaction in Diabetes Mellitus Excerpta Medica; Amsterdam: 1982: 70-76.
    Search in Google Scholar
  • 45 Newburgh L. H, Conn J. W. A new interpretation of hyperglycaemia in obese middle aged persons. JAMA 1939; 112: 7-11.
    CrossrefPubMedSearch in Google Scholar
  • 46 DeFronzo R. Glucose intolerance and aging. Evidence for tissue insensitivity to insulin. Diabetes 1979; 28: 1095-1101.
    CrossrefPubMedSearch in Google Scholar
  • 47 Pyke D. A. Diabetes: The genetic connections. Diabetologia 1979; 17: 333-343.
    CrossrefPubMedSearch in Google Scholar
  • 48 West K. M, Kalbfleisch J. M. Influence of nutritional factors on prevalence of diabetes. Diabetes 1971; 20: 99-108.
    CrossrefPubMedSearch in Google Scholar
  • 49 Baird J. D. Diet and the development of clinical diabetes. Acta diabetol. Lat 1972; 9 Suppl (Suppl. 01) 621-637.
    PubMedSearch in Google Scholar
  • 50 Blair A. L. T. Dietary management of maturity onset diabetes. MD Thesis. The Queen’s University of Belfast.
    PubMed
  • 51 Williams D. R. R, James W. P. T, Evans I. E. Dietary fibre supplementation of a “normal” breakfast administered to diabetics. Diabetologia 1980; 18: 379-381.
    PubMedSearch in Google Scholar
  • 52 Vierhapper H, Bratusch-Marrain P, Waldhäusl W. A-Glucoside hydrolase inhibition in diabetics. Lancet I: 1386 1979; (Letter to the Editor.)
    PubMedSearch in Google Scholar
  • 53 Reaven G. M. How high the carbohydrate?. Diabetologia 1980; 19: 409-413.
    CrossrefPubMedSearch in Google Scholar
  • 54 Maske H. Oral wirksame Antidiabetika. Handb. Exp. Pharm. XXIX. Springer; Berlin – Heidelberg – New York: 1971
    Search in Google Scholar
  • 55 Olefsky J. M, Reaven G. M. Effects of sulfonylurea therapy on insulin-binding to mononuclear leucocytes of diabetic patients. Am. J. Med 1976; 60: 89-95.
    CrossrefPubMedSearch in Google Scholar
  • 56 Meinert C. L, Knatterud G. L, Prout T. E, Klimt C. R. The University Group Diabetes Program (UGDP): A study of the effects of hypoglycaemic agents on vascular complications in patients with adult onset diabetes. II. Mortality Results. Diabetes 19 Suppl 1970; 789-830.
    PubMedSearch in Google Scholar
  • 57 Kilo C, Miller J. P, Williamson J. R. The Achilles heel of the University Group Diabetes Program. JAMA 1980; 243: 450-457.
    CrossrefPubMedSearch in Google Scholar
  • 58 Czyzyk A, Lawecki J, Sadowski J, Panikowska J, Scepanik Z. Effect of bigu-anide on intestinal absorption of glucose. Diabetes 1968; 17: 492-498.
    CrossrefPubMedSearch in Google Scholar
  • 59 Dietze G, Wicklmayr M, Mehnert H, Czempiel H, Henftling H. G. Effect of phen-formin on hepatic balances of gluconeogenic substrates in man. Diabetologia 1978; 14: 243-248.
    CrossrefPubMedSearch in Google Scholar
  • 60 Butterfield W. J. H, Whichelow M. H. The hypoglycaemic action of phenformin on glucose metabolism in peripheral tissues. Diabetes 1962; 11: 281-286.
    PubMedSearch in Google Scholar
  • 61 Bratusch-Marrain P, Korn A, Waldhäusl W. K, Gasić S, Nowotny P. Effect of biguanide on splanchnic carbohydrate and substrate metabolism in healthy man. Metabolism 1981; 30: 946-952.
    CrossrefPubMedSearch in Google Scholar
  • 62 Luft D, Schmülling R. M, Eggstein M. Lactic acidosis in biguanide treated diabetics. Diabetologia 1978; 14: 75-87.
    CrossrefPubMedSearch in Google Scholar